| 2009–2011 | 2012–2016 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Age group(s) | Number of cases (n) | 0 dose(%) | 1 dose (%) | ≥2 doses (%) | Unknown (%) | Number of cases (n) | 0 dose (%) | 1 dose (%) | ≥2 doses (%) | Unknown (%) |
0–8 months | 548 | 66.1 | 7.3 | 0.0 | 26.4 | 5862 | 91.2 | 3.0 | 0.0 | 5.8 |
9–23 months | 769 | 28.9 | 32.6 | 3.8 | 34.7 | 4551 | 70.7 | 15.1 | 0.4 | 13.7 |
2–6 years | 473 | 21.1 | 10.1 | 16.5 | 52.2 | 2646 | 53.7 | 9.6 | 7.6 | 29.1 |
7–15 years | 315 | 7.9 | 8.9 | 11.1 | 72.1 | 761 | 33.0 | 10.0 | 10.5 | 46.5 |
16–24 years | 558 | 20.6 | 5.0 | 1.4 | 73 | 1431 | 17.9 | 4.2 | 1.3 | 76.6 |
≥25 years | 531 | 16.6 | 2.4 | 0.6 | 80.4 | 3917 | 16.4 | 2.0 | 0.4 | 81.3 |
Total | 3194 | 28.6 | 12.8 | 4.8 | 53.9 | 19,168 | 58.1 | 7.0 | 1.8 | 33.2 |